Metis Global Partners LLC Boosts Stock Position in STERIS plc (NYSE:STE)

Metis Global Partners LLC increased its stake in shares of STERIS plc (NYSE:STE - Free Report) by 24.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,772 shares of the medical equipment provider's stock after purchasing an additional 1,322 shares during the period. Metis Global Partners LLC's holdings in STERIS were worth $1,392,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. QRG Capital Management Inc. lifted its holdings in STERIS by 32.9% in the 4th quarter. QRG Capital Management Inc. now owns 1,273 shares of the medical equipment provider's stock valued at $262,000 after purchasing an additional 315 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in shares of STERIS in the fourth quarter worth about $9,895,000. Mn Services Vermogensbeheer B.V. boosted its position in STERIS by 1.8% during the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 38,600 shares of the medical equipment provider's stock worth $7,935,000 after acquiring an additional 700 shares during the last quarter. New York Life Investment Management LLC grew its stake in STERIS by 1.2% during the 4th quarter. New York Life Investment Management LLC now owns 14,781 shares of the medical equipment provider's stock valued at $3,038,000 after acquiring an additional 180 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund grew its stake in STERIS by 0.8% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 8,459 shares of the medical equipment provider's stock valued at $1,739,000 after acquiring an additional 65 shares in the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

STERIS Trading Up 0.3 %

STE traded up $0.77 during trading hours on Friday, reaching $233.02. The company's stock had a trading volume of 658,831 shares, compared to its average volume of 519,349. The stock has a market cap of $22.89 billion, a PE ratio of 49.47 and a beta of 0.92. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The business's 50-day moving average is $216.46 and its 200-day moving average is $222.86.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities research analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Thursday, February 20th. STERIS's dividend payout ratio is presently 48.41%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on STE shares. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research note on Friday, November 8th. JMP Securities reiterated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler upped their target price on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Finally, Stephens reiterated an "overweight" rating and set a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, STERIS currently has an average rating of "Moderate Buy" and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.